<p>, /PRNewswire/ -- Kuehn Law, PLLC，一家股东诉讼律师事务所，正在调查 <strong>DexCom, Inc. (NASDAQ: DXCM)</strong> 的某些高管和董事是否违反了对股东的信托责任。</p>
<p>根据一项联邦证券诉讼，DexCom 内部人士导致公司对 2024 财年的预期收入进行了错误陈述或未能披露重要信息。2024 年 7 月 25 日，Dexcom 公布了 2024 财年第二季度的财务业绩，并下调了 2024 财年全年的收入指引。公司将其业绩和下调指引归因于其执行的 “几项关键战略举措”，这些举措 “未能达到他们的高标准”。在这一消息发布后，DexCom 的股价跌至 64.00 美元，下降约 40.66%。</p>
<p>如果您目前持有 DXCM <strong>并在 2023 年 4 月 28 日之前购买</strong>，请通过电子邮件联系 Justin Kuehn, Esq.，邮箱为 [email protected]，或拨打 (833) 672-0814。<strong>Kuehn Law 承担所有案件费用，并不向投资者客户收费。</strong> <em>股东应立即联系该事务所，因为您可能有有限的时间来维护您的权利。</em></p>
<p><strong>您参与的重要性：</strong></p>
<p>作为股东，您的声音很重要，通过参与，您为金融市场的诚信和公平做出贡献。<em>您的投资。您的声音。您的未来。</em> ™</p>
<p>有关更多信息，请访问股东衍生诉讼 - Kuehn Law。</p>
<p>律师广告。以往的结果并不保证类似的结果。</p>
<p>联系方式：</p>
<p>Kuehn Law, PLLC</p>
<p>Justin Kuehn, Esq.</p>
<p>53 Hill Street, Suite 605</p>
<p>Southampton, NY 11968</p>
<p>[email protected]</p>
<p>(833) 672-0814</p>
<p>来源 Kuehn Law, PLLC</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9Tlk3NzkwOCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA3UFJfTkVXU19VU1BSX19fX19OWTc3OTA4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9Tlk3NzkwOCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA3UFJfTkVXU19VU1BSX19fX19OWTc3OTA4"/></p>

德康医疗

<p>Kuehn Law, PLLC 正在调查 DexCom, Inc.（纳斯达克代码：DXCM）高管和董事可能违反信托责任的情况，此次调查是基于一起联邦证券诉讼。诉讼声称 DexCom 内部人士对 2024 财年的收入预期进行了虚假陈述，导致公司下调收入指引后，股价大幅下跌约 40.66%。鼓励在 2023 年 4 月 28 日之前购买 DXCM 的股东联系 Kuehn Law 以寻求潜在的法律行动，因为该公司将承担所有案件费用</p>

<p>, /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of <strong>DexCom, Inc. (NASDAQ: DXCM)</strong> breached their fiduciary duties to shareholders.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Kuehn Law, PLLC，一家股东诉讼律师事务所，正在调查 <strong>DexCom, Inc. (NASDAQ: DXCM)</strong> 的某些高管和董事是否违反了对股东的信托责任。</p>
</div><p>According to a federal securities lawsuit, DexCom insiders caused the company to misrepresent or fail to disclose material information concerning expected revenue for the fiscal year 2024. On July 25, 2024, Dexcom announced its financial results for the second quarter of fiscal 2024 and reduced its revenue guidance for the full fiscal year 2024. The Company attributed its results and lowered guidance on their execution of &#34;several key strategic initiatives&#34; which &#34;did not meet [their] high standards.&#34; On this news, DexCom's stock price fell to $64.00, a decline of about 40.66%.</p>
<div class="lb-trans"><p>根据一项联邦证券诉讼，DexCom 内部人士导致公司对 2024 财年的预期收入进行了错误陈述或未能披露重要信息。2024 年 7 月 25 日，Dexcom 公布了 2024 财年第二季度的财务业绩，并下调了 2024 财年全年的收入指引。公司将其业绩和下调指引归因于其执行的 “几项关键战略举措”，这些举措 “未能达到他们的高标准”。在这一消息发布后，DexCom 的股价跌至 64.00 美元，下降约 40.66%。</p>
</div><p>If you currently own DXCM <strong>and purchased prior to April 28, 2023</strong> please contact Justin Kuehn, Esq. here, by email at [email protected] or call (833) 672-0814. <strong>Kuehn Law pays all case costs and does not charge its investor clients.</strong> <em>Shareholders should contact the firm immediately as there may be limited time to enforce your rights.</em></p>
<div class="lb-trans"><p>如果您目前持有 DXCM <strong>并在 2023 年 4 月 28 日之前购买</strong>，请通过电子邮件联系 Justin Kuehn, Esq.，邮箱为 [email protected]，或拨打 (833) 672-0814。<strong>Kuehn Law 承担所有案件费用，并不向投资者客户收费。</strong> <em>股东应立即联系该事务所，因为您可能有有限的时间来维护您的权利。</em></p>
</div><p><strong>Why Your Participation Matters:</strong></p>
<div class="lb-trans"><p><strong>您参与的重要性：</strong></p>
</div><p>As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. <em>Your investment. Your voice. Your future.</em> ™</p>
<div class="lb-trans"><p>作为股东，您的声音很重要，通过参与，您为金融市场的诚信和公平做出贡献。<em>您的投资。您的声音。您的未来。</em> ™</p>
</div><p>For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.</p>
<div class="lb-trans"><p>有关更多信息，请访问股东衍生诉讼 - Kuehn Law。</p>
</div><p>Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>律师广告。以往的结果并不保证类似的结果。</p>
</div><p>Contacts:</p>
<div class="lb-trans"><p>联系方式：</p>
</div><p>Kuehn Law, PLLC</p>
<div class="lb-trans"><p>Kuehn Law, PLLC</p>
</div><p>Justin Kuehn, Esq.</p>
<div class="lb-trans"><p>Justin Kuehn, Esq.</p>
</div><p>53 Hill Street, Suite 605</p>
<div class="lb-trans"><p>53 Hill Street, Suite 605</p>
</div><p>Southampton, NY 11968</p>
<div class="lb-trans"><p>Southampton, NY 11968</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>(833) 672-0814</p>
<div class="lb-trans"><p>(833) 672-0814</p>
</div><p>SOURCE Kuehn Law, PLLC</p>
<div class="lb-trans"><p>来源 Kuehn Law, PLLC</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUwOTE5Jk5ld3NJdGVtSWQ9Tlk3NzkwOCZUcmFuc21pc3Npb25fSWQ9MjAyNTA5MTkxNDA3UFJfTkVXU19VU1BSX19fX19OWTc3OTA4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY77908&amp;Transmission_Id=202509191407PR_NEWS_USPR_____NY77908&amp;DateId=20250919"/></p>

Kuehn Law 鼓励 DexCom, Inc. 的投资者联系律师事务所